Metraipolis › archive › dc_7002eb6f8edb
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters — Europe PMC PMID:34499677
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/34499677
- DOI
- 10.1371/journal.pone.0257191
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-02T20:51:10.026Z
- SHA-256 of the archived text
e0368bbc0db98868e3ac450977b54c46d9bf26329169ad9de46b5792ced8ec1c- Stable URL of this page
https://metraipolis.com/documento/dc_7002eb6f8edb
How to cite
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters — Europe PMC PMID:34499677 — Europe PMC (en), https://europepmc.org/article/MED/34499677 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_7002eb6f8edb (Metraipolis archive dc_7002eb6f8edb, sha256 e0368bbc0db98868e3ac450977b54c46d9bf26329169ad9de46b5792ced8ec1c)
BibTeX
@misc{dc7002eb6f8edb,
title = {Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters — Europe PMC PMID:34499677},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/34499677},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_7002eb6f8edb; sha256 e0368bbc0db98868e3ac450977b54c46d9bf26329169ad9de46b5792ced8ec1c},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34499677. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
COVID-19 in humans is caused by Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that belongs to the beta family of coronaviruses. SARS-CoV-2 causes severe respiratory illness in 10-15% of infected individuals and mortality in 2-3%. Vaccines are urgently needed to prevent infection and to contain viral spread. Although several mRNA- and adenovirus-based vaccines are highly effective, their dependence on the "cold chain" transportation makes global vaccination a difficult task. In this context, a stable lyophilized vaccine may present certain advantages. Accordingly, establishing additional vaccine platforms remains vital to tackle SARS-CoV-2 and any future variants that may arise. Vaccinia virus (VACV) has been used to eradicate smallpox disease, and several attenuated viral strains with enhanced safety for human applications have been developed. We have generated two candidate SARS-CoV-2 vaccines based on two vaccinia viral strains, MVA and v-NY, that express full-length SARS-CoV-2 spike protein. Whereas MVA is growth-restricted in mammalian cells, the v-NY strain is replication-competent. We demonstrate that both candidate recombinant vaccines induce high titers of neutralizing antibodies in C57BL/6 mice vaccinated according to prime-boost regimens. Furthermore, our vaccination regimens generated TH1-biased immune responses in mice. Most importantly, prime-boost vaccination of a Syrian hamster infection model with MVA-S and v-NY-S protected the hamsters against SARS-CoV-2 infection, supporting that these two vaccines are promising candidates for future development. Finally, our vaccination regimens generated neutralizing antibodies that partially cross-neutralized SARS-CoV-2 variants of concern. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-09-09). Identificativi: PMID 34499677 · PMCID PMC8428573 · DOI 10.1371/journal.pone.0257191. Pagina: https://europepmc.org/article/MED/34499677 — https://doi.org/10.1371/journal.pone.0257191. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-02T20:43:27.458Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.